Strategic partnership to rapidly bring monkeypox test kits to market
A strategic partnership between WeTrade Group and Jiqing Biomedical Technology hopes to rapidly bring monkeypox virus test kits to market and open antigen test sale channels.
Emerging growth company WeTrade Group Inc. have announced their strategic partnership with Jiqing Biomedical Technology in an effort to provide exclusive monkeypox virus test kits and antigen test sale channels for the development of domestic and international markets. This will mark WeTrade Group’s expansion into the medical industry.
As an innovative biotechnology company, Jiqing focuses on medical research and experimental development with an emphasis on technological innovation. In response to the COVID-19 pandemic, Jiqing created an antigen self-test kit fully approved by the EU, with subsequent product registration certificates obtained for countries including the UK MHRA, Thailand FD, EU CE, German Bfarm, Netherlands CIBG, and Malaysia MDA. With the emergence and spread of monkeypox, Jiqing developed a nucleic acid RT-LAMP test and a colloidal gold technique antigen test.
Working with Jiqing, WeTrade Group will leverage its digital tools to rapidly bring monkeypox virus test kits to market with the power of YCloud, a cloud intelligent system for microbusinesses, and its industry accumulation in computer technology and big data.
CEO of WeTrade Group Piun Liu stated: “The COVID pandemic has caused tremendous harm to the public and the monkeypox has caused significant impact on people in several countries. To solve the issue, we are looking forward to the cooperation between us and Jiqing. We hope to bring the two monkeypox virus test kits to the market as soon as possible by technology empowerment to help prevent and control the virus, and to reduce the harm for the public worldwide.”
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance